Adam Keeney
Patrimonio netto: 1 M $ in data 31/05/2026
Patrimonio netto: 1 M $ in data 31/05/2026
Adam Keeney is Executive VP & Head-Corporate Development at Biogen, Inc. since 2023.
Formerly, Dr. Keeney was President, Chief Executive Officer & Director at NodThera Ltd. from 2018 to 2022.
Dr. Keeney completed undergraduate studies at the University of Leeds and earned a doctorate from The University of Nottingham.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/05/2026 | 6.365 ( 0% ) | 1 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 17/04/2023 |
| Società | Posizione | Fine |
|---|---|---|
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Amministratore Delegato | 01/01/2022 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
University of Leeds
University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Nottingham
The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale